Viskase Holdings Inc 's Revenue in the fiscal year 2025 $ 1.92 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2024 $ 0.03 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2023 $ 2.26 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2022 $ 0.03 millions
Viskase Holdings Inc 's Revenue in the fiscal year 2021 $ 0.70 millions
ENZN Revenue third quarter 2026 Y/Y Growth Comment
Viskase Holdings inc achieved in the third quarter 2026, above Company average Revenue surge of 18955.8% year on year, to $ 95.28 millions.
Looking into third quarter 2026 results within Biotechnology & Pharmaceuticals industry 22 other companies have achieved higher Revenue growth. While Viskase Holdings Inc ' s Revenue doubling of 18955.8% ranks overall at the positon no. 618 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Viskase Holdings Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
20040.52 %
512.4 %
-100 %
(Mar 31 2026)
ENZN's III. Quarter Q/Q Revenue Comment
Viskase Holdings inc achieved in the III. Quarter 2026 below company average Revenue increase of 5.71% quarter on quarter, to $ 95.28 millions.
Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the 0% growth in the III. Quarter a year ago
Within Biotechnology & Pharmaceuticals industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Viskase Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1171.
Viskase Holdings inc achieved in the III. Quarter 2026 below company average Revenue increase of 5.71% quarter on quarter, to $ 95.28 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the III. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Viskase Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1171.
Viskase Holdings Inc 's 12 Months Revenue Growth Year on Year
Viskase Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 18955.8% year on year, to $ 272 millions if the fiscal year would have ended in Sep 30 2026. Viskase Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 171.55% and higher than % growth in Jun 30 2026. But from twelve months ended Jun 30 2026 rise was beneth at 53.53 % from $177.05 millions achieved in the period from Jun 30 2026 to Sep 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at171.55%.
In the Healthcare sector 218 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1204, from total ranking in previous quarter at 3107.
Viskase Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 18955.8% year on year, to $ 272 millions if the fiscal year would have ended in Sep 30 2026. Viskase Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 171.55% and higher than % growth in Jun 30 2026. But from twelve months ended Jun 30 2026 rise was beneth at 53.53 % from $177.05 millions achieved in the period from Jun 30 2026 to Sep 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at171.55%. The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 53.53 % increase from $177.05 millions in the period from Jun 30 2026 to Sep 30 2025.
In the Healthcare sector 218 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1204, from total ranking in previous quarter at 3107.
About Viskase Holdings Inc Revenue Growth Rates (ENZN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
19,109.48%